Mr Bryan Haynes, DDS | |
1249 Powell St, Emeryville, CA 94608 | |
(510) 652-3070 | |
(510) 652-0387 |
Full Name | Mr Bryan Haynes |
---|---|
Gender | Male |
Speciality | Dentist - General Practice |
Location | 1249 Powell St, Emeryville, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1598128373 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1223G0001X | Dentist - General Practice | 031066 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr Bryan Haynes, DDS 1249 Powell St, Emeryville, CA 94608 Ph: (510) 652-3070 | Mr Bryan Haynes, DDS 1249 Powell St, Emeryville, CA 94608 Ph: (510) 652-3070 |
News Archive
Representatives from 35 major health and medical organizations including, the American Diabetes Association (ADA), American Medical Association (AMA), American Heart Association (AHA), American Academy of Orthopaedic Surgeons (AAOS), and American Society of Clinical Oncology (ASCO) convened for a second annual summit in Chicago to identify opportunities for collaboration in treating obesity. "The National Obesity Summit on the Provision of Care for the Obese Patient" was hosted by the American Society for Metabolic and Bariatric Surgery (ASMBS).
Every week, KHN reporter Shefali S. Kulkarni compiles a selection of recently-released health policy studies and briefs.
Boston Scientific Corporation today announced that the U.S. Court of Appeals for the Federal Circuit affirmed the decision of the U.S. District Court for the District of Delaware, finding all four patents in a suit involving Johnson & Johnson to be invalid.
Gilead Sciences, Inc. announced Phase II clinical trial results today showing that its investigational fixed-dose single-tablet "Quad" regimen of elvitegravir, GS 9350 (cobicistat) and Truvada® (emtricitabine and tenofovir disoproxil fumarate) for the treatment of HIV infection exhibited antiretroviral activity comparable to that of Atripla® (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg).
Researchers at the Chongqing Medical University in China have identified a cytokine that could serve as a potential candidate for treating patients with severe coronavirus disease 2019 (COVID-19).
› Verified 5 days ago
William On, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 5901 Christie Ave Ste 106, Emeryville, CA 94608 Phone: 510-210-1345 | |
Rose Magno, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 6001 Shellmound St Ste 125, Emeryville, CA 94608 Phone: 510-595-1600 | |
Emma Pollack, D.M.D Dentist Medicare: Medicare Enrolled Practice Location: 1001 46th St, #322, Emeryville, CA 94608 Phone: 646-319-6988 | |
Dr. Chong Pei Nikki Pung-yamato, DDS Dentist Medicare: Medicare Enrolled Practice Location: 6399 Christie Ave, #338, Emeryville, CA 94608 Phone: 510-260-5151 | |
Dr. Jnana Patel, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 5901 Christie Ave, Suite #106, Emeryville, CA 94608 Phone: 510-658-9775 | |
Dr. William Arthur Allison, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 2334 Powell St, Emeryville, CA 94608 Phone: 510-652-8855 Fax: 510-652-6949 |